drugset / Trial / NCT05428826
Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis
NaSingle-groupOpen-labelTreatment
Summary
Adult patients with a diagnosis of idiopathic retroperitoneal fibrosis Prospective multicentric cohort study Intervention : administration of prednisone during 9 to 21 months at 1mg/kg/day at inclusion.
Timeline
- Start
- 2022-11-25
- Primary completion
- 2026-11-25
- Completion
- 2028-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisone | Other / unclassified | 1 mg/kg | Oral |
Indications
No indication recorded.